In an industry overflowing with buzzwords like “immersive content” and “omnichannel orchestration,” it is easy to lose sight of what truly drives healthcare professionals (HCPs) to engage: usefulness.
The ASCO Annual Meeting is known for electrifying the oncology and pharmaceutical industries with fresh insights, emerging trends, and glimpses into the future of cancer care.
Matt Holland, Chief Operating Officer, Healio attended Cleveland Clinic’s inaugural A.I. Summit for Healthcare Professionals earlier this month, leaving him feel empowered and energized by the transformative role AI is playing in healthcare.
From point-of-care decision support to accessing up-to-date treatment guidelines, doctors and clinicians are increasingly seeing the value of AI assistants in their daily work.
Marti Washburn Giunto, Senior Director, Health Tech at HSS, shares insights gleaned from the McGuireWoods Healthcare Private Equity and Finance Conference in May 2025.
John Carter, Chief Strategy Officer of Healio attended Capitol Hill Day hosted by the American Association of Advertising Agencies (4As) and Association of National Advertisers (ANA) on Wednesday, May 7.
In pharmaceutical media — a space defined by complexity, strict regulation, and entrenched silos — genuine connection often takes a back seat. Solli was created to change that [...]
Dave Mullin, Senior Director, Business Development & Market Strategy, Eyecare, shares insight from American Academy of Ophthalmology (AAO) annual meeting in Chicago.
Richard Springham, CEO of solli, a new B2B platform serving those working within pharmaceutical media, discusses the reasons behind launching solli, the platform’s objectives, and its progress in the first few months.
One of the hottest topics in 2024 is how AI — and specifically generative AI, or GenAI, which can actually create content — is poised to change the way pharmaceutical companies market their products to healthcare professionals (HCPs).
Never miss a post! Subscribe to receive HSS Viewpoint updates.